UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update

Journal of clinical oncology, 2020-10, Vol.38 (28), p.3325-3348

2020

Volltextzugriff (PDF)

The impact of SBF2 on taxane-induced peripheral neuropathy

PLoS genetics, 2022-01, Vol.18 (1), p.e1009968

2022

Volltextzugriff (PDF)

Optimization of a human induced pluripotent stem cell-derived sensory neuron model for the in vitro evaluation of taxane-induced neurotoxicity

Scientific reports, 2024-08, Vol.14 (1), p.19075-8

2024

Volltextzugriff (PDF)

Triple-Negative Breast Cancer: Risk Factors to Potential Targets

Clinical cancer research, 2008-12, Vol.14 (24), p.8010-8018

2008

Volltextzugriff (PDF)

Identification of germline cancer predisposition variants during clinical ctDNA testing

Scientific reports, 2021-07, Vol.11 (1), p.13624-13624, Article 13624

2021

Volltextzugriff (PDF)

Association of Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor Receptor-2 Genetic Polymorphisms With Outcome in a Trial of Paclitaxel Compared With Paclitaxel Plus Bevacizumab in Advanced Breast Cancer: ECOG 2100

Journal of clinical oncology, 2008-10, Vol.26 (28), p.4672-4678

2008

Volltextzugriff (PDF)

Genome-Wide Association Studies for Taxane-Induced Peripheral Neuropathy in ECOG-5103 and ECOG-1199

Clinical cancer research, 2015-11, Vol.21 (22), p.5082-5091

2015

Volltextzugriff (PDF)

Passage number affects differentiation of sensory neurons from human induced pluripotent stem cells

Scientific reports, 2022-09, Vol.12 (1), p.1-9, Article 15869

2022

Volltextzugriff (PDF)

Phase II trial of carboplatin and bevacizumab in patients with breast cancer brain metastases

Breast cancer research : BCR, 2020-11, Vol.22 (1), p.131-131, Article 131

2020

Volltextzugriff (PDF)

Altered cerebral blood flow one month after systemic chemotherapy for breast cancer: a prospective study using pulsed arterial spin labeling MRI perfusion

PloS one, 2014-05, Vol.9 (5), p.e96713

2014

Volltextzugriff (PDF)

A phase II clinical trial of the Aurora and angiogenic kinase inhibitor ENMD-2076 for previously treated, advanced, or metastatic triple-negative breast cancer

Breast cancer research : BCR, 2018-08, Vol.20 (1), p.82-82, Article 82

2018

Volltextzugriff (PDF)

Profiling molecular regulators of recurrence in chemorefractory triple-negative breast cancers

Breast cancer research : BCR, 2019-08, Vol.21 (1), p.87-87, Article 87

2019

Volltextzugriff (PDF)

Heterozygous deletion of chromosome 17p renders prostate cancer vulnerable to inhibition of RNA polymerase II

Nature communications, 2018-10, Vol.9 (1), p.4394-15, Article 4394

2018

Volltextzugriff (PDF)

Molecular and clinical effects of aromatase inhibitor therapy on skeletal muscle function in early-stage breast cancer

Scientific reports, 2024-01, Vol.14 (1), p.1029-1029, Article 1029

2024

Volltextzugriff (PDF)

Clinically significant germline pathogenic variants are missed by tumor genomic sequencing

Npj genomic medicine, 2023-10, Vol.8 (1), p.30-30, Article 30

2023

Volltextzugriff (PDF)

A large microRNA cluster on chromosome 19 is a transcriptional hallmark of WHO type A and AB thymomas

British journal of cancer, 2016-02, Vol.114 (4), p.477-484

2016

Volltextzugriff (PDF)

Incremental Prognostic Value of Echocardiographic Strain and Its Association With Mortality in Cancer Patients

Journal of the American Society of Echocardiography, 2015-06, Vol.28 (6), p.667-673

2015

Volltextzugriff (PDF)

The Role of Vascular Endothelial Growth Factor Genetic Variability in Cancer

Clinical cancer research, 2009-09, Vol.15 (17), p.5297-5302

2009

Volltextzugriff (PDF)

Life-Threatening Docetaxel Toxicity in a Patient With Reduced-Function CYP3A Variants: A Case Report

Frontiers in oncology, 2022-01, Vol.11, p.809527

2022

Volltextzugriff (PDF)

Neuropathy Is Not Associated With Clinical Outcomes in Patients Receiving Adjuvant Taxane-Containing Therapy for Operable Breast Cancer

Journal of clinical oncology, 2012-09, Vol.30 (25), p.3051-3057

2012

Volltextzugriff (PDF)

Pharmacogenetic biomarkers for the prediction of response to antiangiogenic treatment

The lancet oncology, 2012-10, Vol.13 (10), p.e427-e436

2012

Volltextzugriff (PDF)

Clinical benefit of a precision medicine based approach for guiding treatment of refractory cancers

Oncotarget, 2016-08, Vol.7 (35), p.56491-56500

2016

Volltextzugriff (PDF)

Drug Insight: VEGF as a therapeutic target for breast cancer

Nature clinical practice. Oncology, 2007-03, Vol.4 (3), p.181-189

2007

Volltextzugriff (PDF)

Computational pharmacogenotype extraction from clinical next-generation sequencing

Frontiers in oncology, 2023-07, Vol.13, p.1199741-1199741

2023

Volltextzugriff (PDF)

“How is it going to help?”: Exploring Black breast cancer patients’ questions about biomarker testing to predict chemotherapy-induced peripheral neuropathy

PEC innovation, 2023-12, Vol.2, p.100118-100118, Article 100118

2023

Volltextzugriff (PDF)

1 – 25 von 293

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(279)
Mit Volltextzugriff
(250)

Publikationsform

Sprache

Englisch
(293)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(186)
Life Sciences & Biomedicine
(153)
Humans
(143)
Female
(103)
Oncology
(96)
Middle Aged
(62)
Male
(55)
Aged
(53)
Adult
(47)
Breast Cancer
(34)
Biological And Medical Sciences
(29)
Breast Neoplasms - Drug Therapy
(29)
Medical Sciences
(27)
Aged, 80 And Over
(26)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(26)
Treatment Outcome
(23)
Patients
(22)
Tumors
(22)
Chemotherapy
(21)
Multidisciplinary Sciences
(18)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update

The impact of SBF2 on taxane-induced peripheral neuropathy

Optimization of a human induced pluripotent stem cell-derived sensory neuron model for the in vitro evaluation of taxane-induced neurotoxicity

Triple-Negative Breast Cancer: Risk Factors to Potential Targets

Identification of germline cancer predisposition variants during clinical ctDNA testing

Association of Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor Receptor-2 Genetic Polymorphisms With Outcome in a Trial of Paclitaxel Compared With Paclitaxel Plus Bevacizumab in Advanced Breast Cancer: ECOG 2100

Genome-Wide Association Studies for Taxane-Induced Peripheral Neuropathy in ECOG-5103 and ECOG-1199

Passage number affects differentiation of sensory neurons from human induced pluripotent stem cells

Phase II trial of carboplatin and bevacizumab in patients with breast cancer brain metastases

Altered cerebral blood flow one month after systemic chemotherapy for breast cancer: a prospective study using pulsed arterial spin labeling MRI perfusion

A phase II clinical trial of the Aurora and angiogenic kinase inhibitor ENMD-2076 for previously treated, advanced, or metastatic triple-negative breast cancer

Profiling molecular regulators of recurrence in chemorefractory triple-negative breast cancers

Heterozygous deletion of chromosome 17p renders prostate cancer vulnerable to inhibition of RNA polymerase II

Molecular and clinical effects of aromatase inhibitor therapy on skeletal muscle function in early-stage breast cancer

Clinically significant germline pathogenic variants are missed by tumor genomic sequencing

A large microRNA cluster on chromosome 19 is a transcriptional hallmark of WHO type A and AB thymomas

Incremental Prognostic Value of Echocardiographic Strain and Its Association With Mortality in Cancer Patients

The Role of Vascular Endothelial Growth Factor Genetic Variability in Cancer

Life-Threatening Docetaxel Toxicity in a Patient With Reduced-Function CYP3A Variants: A Case Report

Neuropathy Is Not Associated With Clinical Outcomes in Patients Receiving Adjuvant Taxane-Containing Therapy for Operable Breast Cancer

Pharmacogenetic biomarkers for the prediction of response to antiangiogenic treatment

Clinical benefit of a precision medicine based approach for guiding treatment of refractory cancers

Drug Insight: VEGF as a therapeutic target for breast cancer

Computational pharmacogenotype extraction from clinical next-generation sequencing

“How is it going to help?”: Exploring Black breast cancer patients’ questions about biomarker testing to predict chemotherapy-induced peripheral neuropathy

Suchergebnisse filtern